Senti Biosciences Company Top Insiders

Senti Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.6777) % which means that it has lost $0.6777 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.9462) %, meaning that it created substantial loss on money invested by shareholders. Senti Biosciences' management efficiency ratios could be used to measure how well Senti Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.65. The current Return On Capital Employed is estimated to decrease to -0.87. As of now, Senti Biosciences' Net Tangible Assets are increasing as compared to previous years. The Senti Biosciences' current Non Currrent Assets Other is estimated to increase to about 4.4 M, while Total Assets are projected to decrease to under 106.2 M. The current Common Stock Shares Outstanding is estimated to decrease to about 4.3 M. The current Net Loss is estimated to decrease to about (55 M)Senti Biosciences shows a total of 26.29 Million outstanding shares. Senti Biosciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Senti Biosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Senti Biosciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Senti Biosciences Workforce Comparison

Senti Biosciences Insider Trading

Senti Biosciences Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Senti Biosciences often depends on how effective the management is. Senti Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Senti management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Senti management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.